Novonesis (Novozymes) B Class B NSIS B

Morningstar Rating
DKK 460.00 −19.90 (4.15%)
View Full Chart

Company Report

Price vs Fair Value

NSIS B is trading at a LOCK|W@bc!c# premium.
Price
DKK 460.00
Fair Value
>F&
Uncertainty
LOCK|jR%L
1-Star Price
LOCK|KJ
5-Star Price
c$B
Economic Moat
LOCK|@#<
Capital Allocation
LOCK|v^@jPC@

Bulls Say, Bears Say

Bulls

Novonesis holds a dominant market position in enzymes and cultures, with nearly 50% market share in both, supported by an enviable portfolio of patents and an unmatched library of strains and enzyme classes.

Bears

Novonesis' core markets offer relatively low growth prospects, which means the company is now relying more on new markets and inorganic growth initiatives.

Trading Information

Previous Close Price
DKK 479.90
Day Range
DKK 460.00–476.70
52-Week Range
DKK 336.80–484.70
Bid/Ask
DKK 464.00 / DKK 464.30
Shares Outstanding
466.22M
Market Cap
DKK 214.46B
Volume/Avg
890,470 / 620,890

Key Statistics

Price/Earnings (Normalized)
31.75
Price/Sales
6.58
Dividend Yield (Trailing)
1.43%
Dividend Yield (Forward)
1.43%
Dividend Payment Schedule
Mar, Aug
Total Yield
1.43%

Company Profile

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
Sector
Basic Materials
Industry
Specialty Chemicals
Stock Style Box
Large Growth
Total Number of Employees
11,641

Competitors

Valuation

Metric
NSIS B
IFF
GIVN
Price/Earnings (Normalized)
31.7532.9737.51
Price/Book Value
2.561.568.50
Price/Sales
6.582.515.08
Price/Cash Flow
21.2716.9525.81
Price/Earnings
NSIS B
IFF
GIVN

Financial Strength

Metric
NSIS B
IFF
GIVN
Quick Ratio
0.960.370.70
Current Ratio
1.531.871.29
Interest Coverage
13.71−4.0610.87
Quick Ratio
NSIS B
IFF
GIVN

Profitability

Metric
NSIS B
IFF
GIVN
Return on Assets (Normalized)
5.88%2.69%9.24%
Return on Equity (Normalized)
8.85%4.87%24.97%
Return on Invested Capital (Normalized)
7.28%4.00%12.86%
Return on Assets
NSIS B
IFF
GIVN

Specialty Chemicals Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Linde PLC
LIN
LOCK|%^RB?R>LOCK|pP#$237B
Ecolab Inc
ECL
LOCK|<r!&x>tLOCK|PZ#$84B
Sherwin-Williams Co
SHW
LOCK|!K%Ncp#LOCK|%c$83B
Air Products and Chemicals Inc
APD
LOCK|S^QkHjLOCK|bt$68B
PPG Industries Inc
PPG
LOCK|Y#%cWlWLOCK|Gp##K$27B
International Flavors & Fragrances Inc
IFF
LOCK|<bq?l%%LOCK|t&^<$21B
LyondellBasell Industries NV Class A
LYB
LOCK|<%%$yBrLOCK|n<JNq$20B
DuPont de Nemours Inc
DD
LOCK|!Q@W<$qLOCK|K$Fh@$19B
Sociedad Quimica Y Minera De Chile SA ADR
SQM
LOCK|cGdR<&GLOCK|$MKKN$16B
Albemarle Corp
ALB
LOCK|p<#QF$LOCK|btWb$12B

Sponsor Center